Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Genasys Inc.GNSS · Entity 7058 | Director | March 16, 2021 | March 18, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Genasys Inc.
Report date March 16, 2021 · Filed March 18, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 90,383 |
Reported balance
After 2021-03-16 transaction · row 1
1 source rowRow 1 · 2021-03-16 · Grant · Acquired 27,883 · Balance 90,383 F1: On March 16, 2021, the issuer granted to the reporting person 27,883 restricted stock units (RSUs) that vest on the one year anniversary of the date of grant. Each RSU represents a contingent right to receive one share of Genasys Inc. common stock and is eligible to be settled solely in shares of Genasys Inc. common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: On March 16, 2021, the issuer granted to the reporting person 27,883 restricted stock units (RSUs) that vest on the one year anniversary of the date of grant. Each RSU represents a contingent right to receive one share of Genasys Inc. common stock and is eligible to be settled solely in shares of Genasys Inc. common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 16, 2021 Filed Mar 18, 2021 20:55 UTC | Genasys Inc. GNSS · Entity 7058 | GrantCommon Stock | 27,883 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-21-006515 · rdgdoc.xml · nonDerivative · entry 1 McCollum Daniel H · CIK 0001669500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,383 F1 · price: On March 16, 2021, the issuer granted to the reporting person 27,883 restricted stock units (RSUs) that vest on the one year anniversary of the date of grant. Each RSU represents a contingent right to receive one share of Genasys Inc. common stock and is eligible to be settled solely in shares of Genasys Inc. common stock. F1 · acquired: On March 16, 2021, the issuer granted to the reporting person 27,883 restricted stock units (RSUs) that vest on the one year anniversary of the date of grant. Each RSU represents a contingent right to receive one share of Genasys Inc. common stock and is eligible to be settled solely in shares of Genasys Inc. common stock. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 00:05 UTC | Genasys Inc. GNSS · Entity 7058 | SaleCommon Stock | 20,000 | $6.46 | $129,200.00 |
DisclosureSEC source: 0001437749-20-025423 · rdgdoc.xml · nonDerivative · entry 1 McCollum Daniel H · CIK 0001669500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,500 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.40 to $6.65, inclusive. The reporting person undertakes to provide Genasys Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 1 of this Form 4. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 18:54 UTC | Genasys Inc. GNSS · Entity 7058 | SaleCommon stock | 9,900 | $5.58 | $55,242.00 |
DisclosureSEC source: 0001437749-20-013218 · rdgdoc.xml · nonDerivative · entry 2 McCollum Daniel H · CIK 0001669500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,500 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transaction at prices ranging from $5.26 to $5.82, inclusive. The reporting person undertakes to provide to LRAD Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 18:54 UTC | Genasys Inc. GNSS · Entity 7058 | SaleCommon stock | 100 | $5.50 | $550.00 |
DisclosureSEC source: 0001437749-20-013218 · rdgdoc.xml · nonDerivative · entry 1 McCollum Daniel H · CIK 0001669500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,400 Read SEC document |
| March 12, 2020 Filed Mar 12, 2020 22:52 UTC | Genasys Inc. LRAD · Entity 7058 | Exercise / conversionRestricted Stock units · Derivative | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-20-004997 · rdgdoc.xml · derivative · entry 3 McCollum Daniel H · CIK 0001669500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common stock · 30,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: No purchase price, conversion price or exercise price was paid because the restricted stock units converted into shares of common stock on a one-for-one basis. F3 · price: No purchase price, conversion price or exercise price was paid because the restricted stock units converted into shares of common stock on a one-for-one basis. F2 · derivative.exercise_date: The reporting person received a grant of 30,000 RSU's on March 12, 2019. These vested on March 12, 2020 and the reporting person received one share of Genasys Inc. common stock for each RSU. F2 · derivative.expiration_date: The reporting person received a grant of 30,000 RSU's on March 12, 2019. These vested on March 12, 2020 and the reporting person received one share of Genasys Inc. common stock for each RSU. Read SEC document |
| March 12, 2020 Filed Mar 12, 2020 22:52 UTC | Genasys Inc. LRAD · Entity 7058 | Exercise / conversionCommon stock | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-20-004997 · rdgdoc.xml · nonDerivative · entry 2 McCollum Daniel H · CIK 0001669500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · date: The reporting person received a grant of 30,000 RSU's on March 12, 2019. These vested on March 12, 2020 and the reporting person received one share of Genasys Inc. common stock for each RSU. F2 · shares: The reporting person received a grant of 30,000 RSU's on March 12, 2019. These vested on March 12, 2020 and the reporting person received one share of Genasys Inc. common stock for each RSU. F3 · price: No purchase price, conversion price or exercise price was paid because the restricted stock units converted into shares of common stock on a one-for-one basis. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 22:52 UTC | Genasys Inc. LRAD · Entity 7058 | GrantCommon stock | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-20-004997 · rdgdoc.xml · nonDerivative · entry 1 McCollum Daniel H · CIK 0001669500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,500 F1 · security: On March 10, 2020, the issuer granted to the reporting person 30,000 restricted stock units (RSU's) that vest on the one year anniversary of the date of grant. Each RSU represents a contingent right to receive one share of Genasys Inc. common stock and is eligible to be settled solely in shares of Genasys Inc. common stock. F1 · shares: On March 10, 2020, the issuer granted to the reporting person 30,000 restricted stock units (RSU's) that vest on the one year anniversary of the date of grant. Each RSU represents a contingent right to receive one share of Genasys Inc. common stock and is eligible to be settled solely in shares of Genasys Inc. common stock. F1 · price: On March 10, 2020, the issuer granted to the reporting person 30,000 restricted stock units (RSU's) that vest on the one year anniversary of the date of grant. Each RSU represents a contingent right to receive one share of Genasys Inc. common stock and is eligible to be settled solely in shares of Genasys Inc. common stock. Read SEC document |
| December 16, 2019 Filed Dec 17, 2019 00:29 UTC | Genasys Inc. LRAD · Entity 7058 | SaleCommon stock | 12,500 | $3.40 | $42,500.00 |
DisclosureSEC source: 0001437749-19-024488 · rdgdoc.xml · nonDerivative · entry 3 McCollum Daniel H · CIK 0001669500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,500 F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.40 to $3.42, inclusive. The reporting person undertakes to provide to LRAD Corporation or the staff of the Securities Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| December 16, 2019 Filed Dec 17, 2019 14:17 UTC Amendment | Genasys Inc. LRAD · Entity 7058 | SaleCommon stock | 12,500 | $3.40 | $42,500.00 |
DisclosureSEC source: 0001437749-19-024503 · rdgdoc.xml · nonDerivative · entry 3 McCollum Daniel H · CIK 0001669500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,500 F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.40 to $3.42, inclusive. The reporting person undertakes to provide to LRAD Corporation or the staff of the Securities Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. Read SEC document |
| December 13, 2019 Filed Dec 17, 2019 00:29 UTC | Genasys Inc. LRAD · Entity 7058 | SaleCommon stock | 20,000 | $3.43 | $68,600.00 |
DisclosureSEC source: 0001437749-19-024488 · rdgdoc.xml · nonDerivative · entry 2 McCollum Daniel H · CIK 0001669500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.38 to $3.45, inclusive. The reporting person undertakes to provide to LRAD Corporation or the staff of the Securities Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| December 13, 2019 Filed Dec 17, 2019 14:17 UTC Amendment | Genasys Inc. LRAD · Entity 7058 | SaleCommon stock | 20,000 | $3.43 | $68,600.00 |
DisclosureSEC source: 0001437749-19-024503 · rdgdoc.xml · nonDerivative · entry 2 McCollum Daniel H · CIK 0001669500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.38 to $3.45, inclusive. The reporting person undertakes to provide to LRAD Corporation or the staff of the Securities Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| December 12, 2019 Filed Dec 17, 2019 00:29 UTC | Genasys Inc. LRAD · Entity 7058 | SaleCommon stock | 20,000 | $3.47 | $69,400.00 |
DisclosureSEC source: 0001437749-19-024488 · rdgdoc.xml · nonDerivative · entry 1 McCollum Daniel H · CIK 0001669500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.45 to $3.49, inclusive. The reporting person undertakes to provide to LRAD Corporation or the staff of the Securities Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| December 12, 2019 Filed Dec 17, 2019 14:17 UTC Amendment | Genasys Inc. LRAD · Entity 7058 | SaleCommon stock | 20,000 | $3.47 | $69,400.00 |
DisclosureSEC source: 0001437749-19-024503 · rdgdoc.xml · nonDerivative · entry 1 McCollum Daniel H · CIK 0001669500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.45 to $3.49, inclusive. The reporting person undertakes to provide to LRAD Corporation or the staff of the Securities Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| March 20, 2019 Filed Mar 20, 2019 23:23 UTC | Genasys Inc. LRAD · Entity 7058 | Exercise / conversionRestricted Stock Units · Derivative | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-19-005373 · rdgdoc.xml · derivative · entry 2 McCollum Daniel H · CIK 0001669500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: No purchase price, conversion price or exercise price was paid because the restricted stock units converted into shares of common stock on a one-for-one basis. F2 · price: No purchase price, conversion price or exercise price was paid because the restricted stock units converted into shares of common stock on a one-for-one basis. F1 · derivative.exercise_date: The reporting person received a grant of 25,000 Restricted Stock Units (RSUs) on March 20, 2018. These vested on March 20, 2019 and the reporting person received one share of LRAD Corporation common stock for each RSU. F1 · derivative.expiration_date: The reporting person received a grant of 25,000 Restricted Stock Units (RSUs) on March 20, 2018. These vested on March 20, 2019 and the reporting person received one share of LRAD Corporation common stock for each RSU. Read SEC document |
| March 20, 2019 Filed Mar 20, 2019 23:23 UTC | Genasys Inc. LRAD · Entity 7058 | Exercise / conversionCommon stock | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-19-005373 · rdgdoc.xml · nonDerivative · entry 1 McCollum Daniel H · CIK 0001669500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reporting person received a grant of 25,000 Restricted Stock Units (RSUs) on March 20, 2018. These vested on March 20, 2019 and the reporting person received one share of LRAD Corporation common stock for each RSU. F2 · price: No purchase price, conversion price or exercise price was paid because the restricted stock units converted into shares of common stock on a one-for-one basis. Read SEC document |
| March 12, 2019 Filed Mar 14, 2019 01:15 UTC | Genasys Inc. LRAD · Entity 7058 | GrantRestricted Stock Units · Derivative | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-004847 · rdgdoc.xml · derivative · entry 1 McCollum Daniel H · CIK 0001669500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of LRAD common stock. F2 · derivative.exercise_date: RSUs vest on March 12, 2020. Expiration date is not applicable to RSUs. F2 · derivative.expiration_date: RSUs vest on March 12, 2020. Expiration date is not applicable to RSUs. Read SEC document |
| March 20, 2018 Filed Mar 21, 2018 18:23 UTC | Genasys Inc. LRAD · Entity 7058 | GrantRestricted Stock Units · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-005143 · rdgdoc.xml · derivative · entry 1 McCollum Daniel H · CIK 0001669500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 25,000 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of LRAD common stock. F2 · derivative.exercise_date: RSUs vest on March 20, 2019. Expiration date is not applicable to RSUs. F2 · derivative.expiration_date: RSUs vest on March 20, 2019. Expiration date is not applicable to RSUs. Read SEC document |
| March 14, 2018 Filed Mar 16, 2018 21:24 UTC | Genasys Inc. LRAD · Entity 7058 | Exercise / conversionRestricted Stock Units · Derivative | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-18-004905 · rdgdoc.xml · derivative · entry 2 McCollum Daniel H · CIK 0001669500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: No purchase price, conversion price or exercise price was paid because the restricted stock units converted into shares of common stock on a one-for-one basis. F2 · price: No purchase price, conversion price or exercise price was paid because the restricted stock units converted into shares of common stock on a one-for-one basis. F1 · derivative.exercise_date: The reporting person received a grant of 25,000 Restricted Stock Units (RSUs) on March 14, 2017. These vested on March 14, 2018 and the reporting person received one share of LRAD Corporation common stock for each RSU. F1 · derivative.expiration_date: The reporting person received a grant of 25,000 Restricted Stock Units (RSUs) on March 14, 2017. These vested on March 14, 2018 and the reporting person received one share of LRAD Corporation common stock for each RSU. Read SEC document |
| March 14, 2018 Filed Mar 16, 2018 21:24 UTC | Genasys Inc. LRAD · Entity 7058 | Exercise / conversionCommon stock | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-18-004905 · rdgdoc.xml · nonDerivative · entry 1 McCollum Daniel H · CIK 0001669500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reporting person received a grant of 25,000 Restricted Stock Units (RSUs) on March 14, 2017. These vested on March 14, 2018 and the reporting person received one share of LRAD Corporation common stock for each RSU. F2 · price: No purchase price, conversion price or exercise price was paid because the restricted stock units converted into shares of common stock on a one-for-one basis. Read SEC document |
| May 18, 2017 Filed May 19, 2017 16:26 UTC | Genasys Inc. LRAD · Entity 7058 | PurchaseCommon Stock | 5,000 | $1.72 | $8,582.00 |
DisclosureSEC source: 0001437749-17-009644 · rdgdoc.xml · nonDerivative · entry 3 McCollum Daniel H · CIK 0001669500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Read SEC document |
| May 18, 2017 Filed May 19, 2017 16:26 UTC | Genasys Inc. LRAD · Entity 7058 | PurchaseCommon Stock | 5,000 | $1.72 | $8,598.00 |
DisclosureSEC source: 0001437749-17-009644 · rdgdoc.xml · nonDerivative · entry 2 McCollum Daniel H · CIK 0001669500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Read SEC document |
| May 17, 2017 Filed May 19, 2017 16:26 UTC | Genasys Inc. LRAD · Entity 7058 | Exercise / conversionRestricted Stock Units · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-17-009644 · rdgdoc.xml · derivative · entry 4 McCollum Daniel H · CIK 0001669500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: No purchase price, conversion price or exercise price was paid because the restricted stock units converted into shares of common stock on a one-for-one basis. F1 · derivative.exercise_date: As reported on a Form 4 filed on March 16, 2017, the reporting person received a grant of 25,000 Restricted Stock Units ("RSUs") on March 14, 2017 which were to vest on May 17, 2017. On the vesting date, for each RSU vesting on such date, the reporting person will receive one share of LRAD Corporation common stock. F1 · derivative.expiration_date: As reported on a Form 4 filed on March 16, 2017, the reporting person received a grant of 25,000 Restricted Stock Units ("RSUs") on March 14, 2017 which were to vest on May 17, 2017. On the vesting date, for each RSU vesting on such date, the reporting person will receive one share of LRAD Corporation common stock. Read SEC document |
| May 17, 2017 Filed May 19, 2017 16:26 UTC | Genasys Inc. LRAD · Entity 7058 | Exercise / conversionCommon Stock | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-17-009644 · rdgdoc.xml · nonDerivative · entry 1 McCollum Daniel H · CIK 0001669500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: As reported on a Form 4 filed on March 16, 2017, the reporting person received a grant of 25,000 Restricted Stock Units ("RSUs") on March 14, 2017 which were to vest on May 17, 2017. On the vesting date, for each RSU vesting on such date, the reporting person will receive one share of LRAD Corporation common stock. F2 · price: No purchase price, conversion price or exercise price was paid because the restricted stock units converted into shares of common stock on a one-for-one basis. Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 18:32 UTC | Genasys Inc. LRAD · Entity 7058 | GrantRestricted Stock Units · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-17-004689 · rdgdoc.xml · derivative · entry 2 McCollum Daniel H · CIK 0001669500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of LRAD common stock. F3 · derivative.exercise_date: RSUs will vest on March 14, 2018. Expiration date is not applicable to RSUs. F3 · derivative.expiration_date: RSUs will vest on March 14, 2018. Expiration date is not applicable to RSUs. Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 18:32 UTC | Genasys Inc. LRAD · Entity 7058 | GrantRestricted Stock Units · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-17-004689 · rdgdoc.xml · derivative · entry 1 McCollum Daniel H · CIK 0001669500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of LRAD common stock. F2 · derivative.exercise_date: RSUs will vest on May 17, 2017. Expiration date is not applicable to RSUs. F2 · derivative.expiration_date: RSUs will vest on May 17, 2017. Expiration date is not applicable to RSUs. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.